October 30th 2024
Bob Rhatigan, CEO of Merz Aesthetics, discusses the organization’s commitment to advancing the aesthetics industry through strategic partnerships, specialized training, and a growing portfolio of injectables and devices.
Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)
View More
Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia
View More
Dermalorian™ Webinar Series on Moderate to Severe Atopic Dermatitis
November 21, 2024 - December 5, 2024
View More
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Ambulatory phlebectomy easily handled
April 1st 2002New Orleans - Ambulatory phlebectomy is a safe and effective outpatient procedure for treating varicose and reticular veins that offers a host of advantages compared with alternative techniques, Mitchel P. Goldman, M.D., said at the annual meeting of the American Academy of Dermatology.
Dermatologists steer clear of in-office surgical mishaps
April 1st 2002New Orleans - The reality of the circumstances surrounding deaths and injuries among patients undergoing office-based surgery is much different from the media portrayal of those events and raises questions about medical board and government regulations aiming to limit the procedures, Brett Coldiron, M.D., said at the annual meeting of the American Academy of Dermatology.
Role of intralesional photocoagulation still cloudy
April 1st 2002New Orleans - Surface treatment with a 1064nm Nd:YAG laser has established value in the management of bleeding vascular birthmarks, but the exact role of intralesional photocoagulation with the laser has yet to be determined, Moise L. Levy, M.D., said at the annual meeting of the American Academy of Dermatology.
Pulsed dye laser option for lesions of lupus
April 1st 2002New Orleans - The pulsed dye laser is a good alternative for treating active cutaneous lesions of lupus having a prominent erythematous component, dermatologists from Madrid's University of Alcala said at the annual meeting of the American Academy of Dermatology.
MF remains diagnosis, treatment challenge
April 1st 2002New Orleans - Even with fairly recent advances in the testing and treatment of mycosis fungoides, difficulties still remain with the diagnosis of the rare, slowly progressing cutaneous lymphoma, David P. Fivenson, M.D., said at the annual meeting of the American Academy of Dermatology.
BCC risk in rhinophyma patients should be taken into account
April 1st 2002New Orleans - Rhinophyma resection needs to be performed in a way that allows for postoperative histopathologic study, according to Luis A. Lopardo, MD, speaking here at the 60th annual meeting of the American Academy of Dermatology.
Trial compares responses to BTX-A, BTX-B
March 1st 2002New Orleans - Results of a preliminary, double-blind, parallel group study demonstrate the efficacy of botulinum toxin type A (BTX-A, Botox) 20 units and botulinum toxin type B (BTX-B, Myobloc) 1,000 and 2,000 units for correcting deep glabellar furrows.
Topical tacrolimus improves vitiligo; adding sunlight may help even more
March 1st 2002New Orleans - Results from an exploratory study indicate a potential role for topical tacrolimus in the management of vitiligo, Emil A. Tanghetti, M.D., said at the annual meeting of the American Academy of Dermatology.
Calcium alginate dressing closes cancer defects
March 1st 2002New Orleans - Second intention healing with a calcium alginate dressing can be a useful alternative for closing skin-cancer excision facial defects in select patients who might otherwise be managed with primary closure, local flaps, or skin grafts, Roger H. Weenig, M.D., M.P.H., said at the annual meeting of the American Academy of Dermatology.